We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
Cap. Flow
+$1.35B
Cap. Flow %
3.15%
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$21.8M
2
CVX icon
Chevron
CVX
+$20.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$19.7M
4
INCY icon
Incyte
INCY
+$17.8M
5
XOM icon
ExxonMobil
XOM
+$16.9M

Top Sells

Rank Stock Value
1
SE
Spectra Energy Corp Wi
SE
+$49.6M
2
STJ
St Jude Medical
STJ
+$41.1M
3
LLTC
Linear Technology Corp
LLTC
+$30.3M
4
HAR
Harman International Industries
HAR
+$13.8M
5
ENH
Endurance Specialty Holdings Ltd
ENH
+$10.3M

Sector Composition

Rank Sector Weight
1 Financials 16.2%
2 Technology 15.06%
3 Healthcare 13.05%
4 Industrials 10.88%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XCO
2776
DELISTED
Exco Resources
XCO
$98K ﹤0.01%
10,491
-1,490
-12% -$15.2K
III icon
2777
Information Services Group
III
$204M
$97K ﹤0.01%
30,894
+1,460
+5% +$4.8K
CDI
2778
DELISTED
CDI Corp.
CDI
$97K ﹤0.01%
+11,316
New +$95.9K
SSI
2779
DELISTED
Stage Stores Inc
SSI
$93K ﹤0.01%
35,909
-4,803
-12% -$12.9K
PFSW
2780
DELISTED
PFSweb, Inc.
PFSW
$93K ﹤0.01%
14,260
+686
+5% +$5.18K
RGLS
2781
DELISTED
Regulus Therapeutics
RGLS
$92K ﹤0.01%
463
+133
+40% +$25.3K
TNGO
2782
DELISTED
Tangoe, Inc.
TNGO
$92K ﹤0.01%
17,295
-25,618
-60% -$175K
PMBC
2783
DELISTED
Pacific Mercantile Bancorp
PMBC
$91K ﹤0.01%
12,078
+715
+6% +$5.33K
AMSC icon
2784
American Superconductor
AMSC
$1.29B
$88K ﹤0.01%
+12,885
New +$86.7K
MRTX
2785
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$88K ﹤0.01%
16,954
+5,325
+46% +$29.2K
IMDZ
2786
DELISTED
Immune Design Corp.
IMDZ
$87K ﹤0.01%
12,798
+647
+5% +$3.74K
AGFS
2787
DELISTED
AgroFresh Solutions Inc
AGFS
$85K ﹤0.01%
19,402
+6,261
+48% +$18.6K
NL icon
2788
NLI Holdings
NL
$289M
$84K ﹤0.01%
+13,090
New +$88.4K
TCS
2789
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$84K ﹤0.01%
1,320
+49
+4% +$3.39K
BPTH
2790
DELISTED
Bio-Path Holdings Inc
BPTH
$84K ﹤0.01%
25
+6
+32% +$21.8K
HLTH
2791
DELISTED
Nobilis Health Corp.
HLTH
$84K ﹤0.01%
49,207
+2,597
+6% +$5.4K
SALM
2792
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$80K ﹤0.01%
+10,764
New +$73.4K
ADVM
2793
DELISTED
Adverum Biotechnologies
ADVM
$78K ﹤0.01%
2,870
+887
+45% +$25.2K
USAK
2794
DELISTED
USA Truck Inc
USAK
$78K ﹤0.01%
+10,562
New +$93.3K
RLH
2795
DELISTED
Red Lions Hotel Corporation
RLH
$78K ﹤0.01%
11,026
+735
+7% +$5.61K
SNAK
2796
DELISTED
Inventure Foods, Inc.
SNAK
$78K ﹤0.01%
17,554
-2,588
-13% -$15.5K
TTOO
2797
DELISTED
T2 Biosystems, Inc
TTOO
$75K ﹤0.01%
3
+1
+50% +$28.1K
ASXC
2798
DELISTED
Asensus Surgical, Inc.
ASXC
$73K ﹤0.01%
4,618
+251
+6% +$4.35K
VSLR
2799
DELISTED
VIVINT SOLAR, INC.
VSLR
$73K ﹤0.01%
26,022
+6,752
+35% +$20.3K
ALJJ
2800
DELISTED
ALJ Regional Holdings Inc
ALJJ
$71K ﹤0.01%
18,979
+4,628
+32% +$17.9K
110 111
112
113 114

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.

  • RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
  • RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
  • RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
  • RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
  • RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
  • RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.

Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.